Updated on 16 September 2026
ELEMENTARY
PostDoc fellow at Istituto Auxologico Italiano
Milan, Italy
About
ELEMENTARY offers a proprietary preclinical screening platform built on patient-derived tumor models specifically developed for rare endocrine cancers, a disease area currently underserved by standard drug discovery pipelines. The platform is designed to identify compounds with direct clinical translatability, significantly reducing the gap between preclinical screening and early-phase clinical application. The platform is currently in validation phase on MTC, with a clear development roadmap toward the broader NET space.
Similar opportunities
Service
ELEMENTARY - compounds validation
Elisa Stellaria Grassi
PostDoc fellow at Istituto Auxologico Italiano
Milan, Italy
Product
ORGANoro - A cardiac organoid based platform for drug screening and personalized medicine
- Buyer
- License partner
- Demonstration / Pilot projects
Beatrice Bassetti
Head Technology Transfer Office at Centro Cardiologico Monzino IRCCS
Milano, Italy
Service
Preclinical and Clinical Due Diligence
- Consulting
- Innovation management
- Research & Development
Salvatore Bianco
Legal Representative AKROS Bioscience at AKROS BIOSCIENCE SRL
POMEZIA, Italy